Unknown

Dataset Information

0

Healthy-like CD4+ Regulatory and CD4+ Conventional T-Cell Receptor Repertoires Predict Protection from GVHD Following Donor Lymphocyte Infusion.


ABSTRACT: Donor lymphocyte infusion (DLI) can (re-)induce durable remission in relapsing patients after allogeneic hematopoietic stem-cell transplantation (alloHSCT). However, DLI harbors the risk of increased non-relapse mortality due to the co-occurrence of graft-versus-host disease (GVHD). GVHD onset may be caused or accompanied by changes in the clonal T-cell receptor (TCR) repertoire. To investigate this, we analyzed T cells in a cohort of 21 patients receiving DLI after alloHSCT. We performed deep T-cell receptor β (TRB) sequencing of sorted CD4+CD25+CD127low regulatory T cells (Treg cells) and CD4+ conventional T cells (Tcon cells) in order to track longitudinal changes in the TCR repertoire. GVHD following DLI was associated with less diverse but clonally expanded CD4+CD25+CD127low Treg and CD4+ Tcon TCR repertoires, while patients without GVHD exhibited healthy-like repertoire properties. Moreover, the diversification of the repertoires upon GVHD treatment was linked to steroid-sensitive GVHD, whereas decreased diversity was observed in steroid-refractory GVHD. Finally, the unbiased sample analysis revealed that the healthy-like attributes of the CD4+CD25+CD127low Treg TCR repertoire were associated with reduced GVHD incidence. In conclusion, CD4+CD25+CD127low Treg and CD4+ Tcon TRB repertoire dynamics may provide a helpful real-time tool to improve the diagnosis and monitoring of treatment in GVHD following DLI.

SUBMITTER: Schneider J 

PROVIDER: S-EPMC9505302 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Healthy-like CD4<sup>+</sup> Regulatory and CD4<sup>+</sup> Conventional T-Cell Receptor Repertoires Predict Protection from GVHD Following Donor Lymphocyte Infusion.

Schneider Jessica J   Kuhlmann Leonie L   Xiao Yankai Y   Raha Solaiman S   Bernhardt Günter G   Stadler Michael M   Thol Felicitas F   Heuser Michael M   Eder Matthias M   Ganser Arnold A   Ravens Sarina S   Förster Reinhold R   Prinz Immo I   Koenecke Christian C   Schultze-Florey Christian R CR  

International journal of molecular sciences 20220918 18


Donor lymphocyte infusion (DLI) can (re-)induce durable remission in relapsing patients after allogeneic hematopoietic stem-cell transplantation (alloHSCT). However, DLI harbors the risk of increased non-relapse mortality due to the co-occurrence of graft-versus-host disease (GVHD). GVHD onset may be caused or accompanied by changes in the clonal T-cell receptor (TCR) repertoire. To investigate this, we analyzed T cells in a cohort of 21 patients receiving DLI after alloHSCT. We performed deep T  ...[more]

Similar Datasets

| S-EPMC6305328 | biostudies-literature
| S-EPMC8474341 | biostudies-literature
| S-EPMC7306996 | biostudies-literature
| S-EPMC8821014 | biostudies-literature
| S-EPMC3763390 | biostudies-literature
| S-EPMC5481316 | biostudies-literature
| S-EPMC7509859 | biostudies-literature
| S-EPMC11822263 | biostudies-literature
| S-EPMC10629738 | biostudies-literature
| S-EPMC7192891 | biostudies-literature